$INFU
InfuSystem Holdings, Inc Stock $infu

$infu Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000143774920023787 Filed on November 13, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$24.71M	$25.13M	$21.49M
YoY Change	13.82%	16.92%	28.85%
Cost Of Revenue	$9.715M	$10.00M	$9.251M
YoY Change	10.86%	8.13%	32.1%
Gross Profit	$15.00M	$15.12M	$12.24M
YoY Change	15.83%	23.57%	26.5%
Gross Profit Margin	60.69%	60.19%	56.95%
Selling, General & Admin	$12.70M	$10.78M	$9.338M
YoY Change	22.6%	15.47%	8.47%
% of Gross Profit	84.7%	71.31%	76.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.533M	$3.560M	$1.177M
YoY Change	176.88%	202.46%	1077.0%
% of Gross Profit	23.56%	23.54%	9.62%
Operating Expenses	$13.96M	$11.87M	$10.58M
YoY Change	19.98%	12.24%	8.25%
Operating Profit	$1.035M	$3.253M	$1.663M
YoY Change	-21.05%	95.61%	-1850.53%
Interest Expense	-$237.0K	$283.0K	$488.0K
YoY Change	-49.36%	-42.01%	31.89%
% of Operating Profit	-22.9%	8.7%	29.34%
Other Income/Expense, Net	-$9.000K	$8.000K	-$11.00K
YoY Change	-65.38%	-172.73%	22.22%
Pretax Income	$789.0K	$2.978M	$1.164M
YoY Change	-3.43%	155.84%	-345.57%
Income Tax	-$9.881M	$38.00K	$29.00K
% Of Pretax Income	-1252.34%	1.28%	2.49%
Net Earnings	$10.67M	$2.940M	$1.135M
YoY Change	1225.47%	159.03%	-318.69%
Net Earnings / Revenue	43.18%	11.7%	5.28%
Basic Earnings Per Share		$0.15	$0.06
Diluted Earnings Per Share	$486.0K	$0.14	$0.05
COMMON SHARES
Basic Shares Outstanding	20.24M	20.18M shares	19.78M
Diluted Shares Outstanding		21.66M shares	20.68M

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.648M	$1.939M	$3.157M
YoY Change	264.49%	-38.58%	-18.68%
Cash & Equivalents	$9.648M	$1.939M	$3.157M
Short-Term Investments
Other Short-Term Assets	$2.402M	$1.587M	$1.605M
YoY Change	44.52%	-1.12%	23.18%
Inventory	$3.001M	$3.973M	$2.768M
Prepaid Expenses
Receivables	$14.72M	$13.93M	$11.46M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$29.77M	$21.43M	$18.99M
YoY Change	54.21%	12.82%	10.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.296M	$4.286M	$2.845M
YoY Change	6.42%	50.65%	90.43%
Goodwill	$0.00
YoY Change
Intangibles	$11.18M	$12.24M	$16.54M
YoY Change	-27.72%	-26.01%	-21.25%
Long-Term Investments
YoY Change
Other Assets	$105.0K	$105.0K	$195.0K
YoY Change	-32.26%	-46.15%	42.34%
Total Long-Term Assets	$67.22M	$58.88M	$58.90M
YoY Change	12.18%	-0.04%	25.92%
TOTAL ASSETS
Total Short-Term Assets	$29.77M	$21.43M	$18.99M
Total Long-Term Assets	$67.22M	$58.88M	$58.90M
Total Assets	$96.99M	$80.31M	$77.90M
YoY Change	22.43%	3.1%	21.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.779M	$6.936M	$10.67M
YoY Change	-14.86%	-34.99%	51.14%
Accrued Expenses			$1.321M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.423M	$7.759M	$7.009M
YoY Change	16.59%	10.7%	46.79%
Total Short-Term Liabilities	$23.00M	$19.70M	$21.81M
YoY Change	5.26%	-9.67%	48.78%
LONG-TERM LIABILITIES
Long-Term Debt	$29.38M	$27.03M	$30.34M
YoY Change	-3.03%	-10.9%	5.87%
Other Long-Term Liabilities	$3.864M	$4.061M	$3.944M
YoY Change	-16.8%	2.97%
Total Long-Term Liabilities	$29.38M	$27.03M	$30.34M
YoY Change	-3.03%	-10.9%	-30.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.00M	$19.70M	$21.81M
Total Long-Term Liabilities	$29.38M	$27.03M	$30.34M
Total Liabilities	$56.24M	$50.92M	$56.18M
YoY Change	-1.14%	-9.36%	-3.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.04M	-$54.71M	-$62.17M
YoY Change	-28.24%	-12.01%	-0.45%
Common Stock	$2.000K	$2.000K	$2.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$40.75M	$29.39M	$21.72M
YoY Change
Total Liabilities & Shareholders Equity	$96.99M	$80.31M	$77.90M
YoY Change	22.43%	3.1%	21.73%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	$10.67M	$2.940M	$1.135M
YoY Change	1225.47%	159.03%	-318.69%
Depreciation, Depletion And Amortization	$3.533M	$3.560M	$1.177M
YoY Change	176.88%	202.46%	1077.0%
Cash From Operating Activities	$7.612M	$8.406M	$5.215M
YoY Change	75.35%	61.19%	55.21%
INVESTING ACTIVITIES
Capital Expenditures	-$4.094M	-$3.357M	-$8.527M
YoY Change	-33.7%	-60.63%	378.78%
Acquisitions
YoY Change
Other Investing Activities	$882.0K	$2.899M	$906.0K
YoY Change	23.7%	219.98%	45.19%
Cash From Investing Activities	-$3.212M	-$458.0K	-$7.621M
YoY Change	-41.19%	-93.99%	558.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.309M	-6.491M	3.861M
YoY Change	441.57%	-268.12%	-659.57%
NET CHANGE
Cash From Operating Activities	7.612M	8.406M	5.215M
Cash From Investing Activities	-3.212M	-458.0K	-7.621M
Cash From Financing Activities	3.309M	-6.491M	3.861M
Net Change In Cash	7.709M	1.457M	1.455M
YoY Change	-1611.57%	0.14%	-3.83%
FREE CASH FLOW
Cash From Operating Activities	$7.612M	$8.406M	$5.215M
Capital Expenditures	-$4.094M	-$3.357M	-$8.527M
Free Cash Flow	$11.71M	$11.76M	$13.74M
YoY Change	11.32%	-14.4%	167.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Type DocumentType	10-Q
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20236932
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2020Q3	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	2300000
	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	6700000
CY2019Q3	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	2000000
	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	5400000
CY2020Q3	infu	Finitelived Intangible Asset Expected Amortization Year Five And After FinitelivedIntangibleAssetExpectedAmortizationYearFiveAndAfter	2101000
CY2020Q3	infu	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3166000
CY2020Q3	infu	Longterm Debt Maturities Repayments Of Principal Year Four And Thereafter LongtermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter	10754000
	dei	Entity Central Index Key EntityCentralIndexKey	0001337013
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Registrant Name EntityRegistrantName	InfuSystem Holdings, Inc
CY2020Q3	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	82445000
CY2019Q4	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	75853000
CY2020Q3	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	786000
CY2019Q4	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	17000
CY2019Q4	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	720000
CY2020Q3	infu	Medical Equipment Net MedicalEquipmentNet	37469000
CY2019Q4	infu	Medical Equipment Net MedicalEquipmentNet	34531000
CY2020Q3	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	53000
CY2020Q3	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	1359000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	1306000
CY2020Q3	infu	Medical Equipment Held For Sale Or Rental Gross MedicalEquipmentHeldForSaleOrRentalGross	1385000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental Gross MedicalEquipmentHeldForSaleOrRentalGross	1334000
CY2020Q3	infu	Medical Equipment Held For Sale Or Rental Reserve MedicalEquipmentHeldForSaleOrRentalReserve	26000
CY2019Q4	infu	Medical Equipment Held For Sale Or Rental Reserve MedicalEquipmentHeldForSaleOrRentalReserve	28000
CY2020Q3	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	36110000
CY2019Q4	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	33225000
CY2020Q3	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	45549000
CY2019Q4	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	41908000
	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	11955000
	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	15005000
CY2020Q3	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	3172000
CY2019Q3	infu	Payments To Acquire Medical Equipment PaymentsToAcquireMedicalEquipment	7410000
CY2020Q3	infu	Revenues External RevenuesExternal	25125000
CY2019Q3	infu	Revenues External RevenuesExternal	21489000
	infu	Revenues External RevenuesExternal	72677000
	infu	Revenues External RevenuesExternal	59405000
CY2020Q3	infu	Revenues Internal RevenuesInternal
CY2019Q3	infu	Revenues Internal RevenuesInternal
	infu	Revenues Internal RevenuesInternal
	infu	Revenues Internal RevenuesInternal
CY2020Q3	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	17000
CY2019Q4	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	66000
CY2020Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Four And Thereafter UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFourAndThereafter	15000
CY2020Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year One UnamortizedValueOfDebtIssuanceCostsPrincipalInYearOne	17000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	29000
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1075000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3225000
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1077000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3326000
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000
CY2020Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Three UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree	17000
CY2020Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Two UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo	17000
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6936000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7962000
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13927000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12097000
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3137000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2648000
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84092000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83699000
CY2019Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	87000
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	528000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	295000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1269000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	70000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	116000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	123000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	190000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	240000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	659000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	770000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1222000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13000
CY2020Q3	us-gaap	Assets Assets	80308000
CY2019Q3	us-gaap	Assets Assets	77895000
CY2019Q4	us-gaap	Assets Assets	79224000
CY2020Q3	us-gaap	Assets Current AssetsCurrent	21426000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	19305000
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1939000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2647000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2647000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4318000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1939000
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3157000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-708000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1161000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23755421
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23400625
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20236932
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19882136
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	2000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10003000
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9251000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28914000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	25470000
CY2020Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	4000
CY2020Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	70000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	16000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	76000
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	120000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	104000
	us-gaap	Depreciation Depreciation	7267000
	us-gaap	Depreciation Depreciation	5727000
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3560000
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3128000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10492000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9053000
CY2020Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	200000
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	600000
CY2019Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	100000
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	300000
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	37549000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	34324000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3930000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1060000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	548000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	548000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2051000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10238000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-869000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	1752000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1490000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	735000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1074000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	514000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2949000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1264000
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8587000
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6936000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24949000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20945000
CY2020Q3	us-gaap	Gross Profit GrossProfit	15122000
CY2019Q3	us-gaap	Gross Profit GrossProfit	12238000
	us-gaap	Gross Profit GrossProfit	43763000
	us-gaap	Gross Profit GrossProfit	33935000
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	150000
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	390000
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2978000
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1164000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6754000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	707000
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	151000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-75000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	233000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	114000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	326000
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1484358
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	897904
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1577065
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	813196
CY2020Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	49787000
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	49787000
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12238000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15463000
CY2020Q3	us-gaap	Interest Expense InterestExpense	283000
CY2019Q3	us-gaap	Interest Expense InterestExpense	488000
	us-gaap	Interest Expense InterestExpense	1018000
	us-gaap	Interest Expense InterestExpense	1436000
CY2020Q3	us-gaap	Inventory Net InventoryNet	3973000
CY2019Q4	us-gaap	Inventory Net InventoryNet	2899000
CY2020Q3	us-gaap	Lease Cost LeaseCost	474000
CY2019Q3	us-gaap	Lease Cost LeaseCost	589000
	us-gaap	Lease Cost LeaseCost	1491000
	us-gaap	Lease Cost LeaseCost	1607000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7575000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1107000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	948000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	940000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1043000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	371000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2435000
CY2020Q3	us-gaap	Liabilities Liabilities	50919000
CY2019Q4	us-gaap	Liabilities Liabilities	56890000
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	80308000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79224000
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19704000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21847000
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	34793000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	38377000
CY2020Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	7759000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8082000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7778000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7053000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7275000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1933000
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	27034000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	30295000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4426000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3486000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8950000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14181000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12668000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9534000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2940000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	1135000
	us-gaap	Net Income Loss NetIncomeLoss	6662000
	us-gaap	Net Income Loss NetIncomeLoss	556000
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	11869000
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	10575000
	us-gaap	Operating Expenses OperatingExpenses	35971000
	us-gaap	Operating Expenses OperatingExpenses	31721000
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3253000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1663000
	us-gaap	Operating Income Loss OperatingIncomeLoss	7792000
	us-gaap	Operating Income Loss OperatingIncomeLoss	2214000
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	410000
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	533000
	us-gaap	Operating Lease Cost OperatingLeaseCost	1238000
	us-gaap	Operating Lease Cost OperatingLeaseCost	1425000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5140000
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4061000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4644000
	us-gaap	Operating Lease Payments OperatingLeasePayments	1130000
	us-gaap	Operating Lease Payments OperatingLeasePayments	1201000
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4784000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5733000
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.078
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.076
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y36D
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y182D
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1587000
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1662000
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	105000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155000
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5009000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5803000
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-71000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1269000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	295000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	865000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1415000
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	250000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	31861000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	7462000
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	3870000
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	2239000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	190000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	237000
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7423000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6685000
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4286000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4037000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	534000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-30000
CY2020Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11000
CY2019Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	160000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	35458000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	3915000
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-54705000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61367000
CY2020Q3	us-gaap	Revenues Revenues	25125000
CY2019Q3	us-gaap	Revenues Revenues	21489000
	us-gaap	Revenues Revenues	72677000
	us-gaap	Revenues Revenues	59405000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	260000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3338000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	29389000
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2196000
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2402000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7263000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7480000
	us-gaap	Share Based Compensation ShareBasedCompensation	1222000
	us-gaap	Share Based Compensation ShareBasedCompensation	780000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250000
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	109000
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	124000
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	20252000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	21719000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	26202000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	20441000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	22334000
CY2020Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	70000
CY2019Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	83000
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	64000
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	56000
	us-gaap	Variable Lease Cost VariableLeaseCost	253000
	us-gaap	Variable Lease Cost VariableLeaseCost	182000
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21663414
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20679431
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21637481
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20503933
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20179056
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19781527
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20060416
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19690737

Files In Submission

Name	View Source	Status
0001437749-20-023787-index-headers.html	Edgar Link	pending
0001437749-20-023787-index.html	Edgar Link	pending
0001437749-20-023787.txt	Edgar Link	pending
0001437749-20-023787-xbrl.zip	Edgar Link	pending
ex_212648.htm	Edgar Link	pending
ex_212649.htm	Edgar Link	pending
ex_212650.htm	Edgar Link	pending
ex_212651.htm	Edgar Link	pending
ex_212652.htm	Edgar Link	pending
ex_212652img001.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
infu-20200930.xml	Edgar Link	completed
infu-20200930.xsd	Edgar Link	pending
infu-20200930_cal.xml	Edgar Link	unprocessable
infu-20200930_def.xml	Edgar Link	unprocessable
infu-20200930_lab.xml	Edgar Link	unprocessable
infu-20200930_pre.xml	Edgar Link	unprocessable
infu20200930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INFU
InfuSystem Holdings, Inc Stock $infu

2020 Q4 Form 10-Q Financial Statement

#000143774920023787 Filed on November 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU InfuSystem Holdings, Inc Stock $infu

2020 Q4 Form 10-Q Financial Statement

#000143774920023787 Filed on November 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU
InfuSystem Holdings, Inc Stock $infu